IL6 and breast carcinoma: Basal-like breast cancers overexpress Interleukin 6 (IL-6), a pro-inflammatory cytokine, and it has been reported that p53 absence triggers an IL-6 dependent epigenetic reprogramming driving breast cancer cells towards a basal-like/stem cell-like gene expression profile [39].